Is more the better?-cetuximab in non-small cell lung cancer patients

^*Corresponding author for this work

Research output: Contribution to journal › Review article › Research › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	S195-S197
Number of pages	3
Journal	Translational Lung Cancer Research
Volume	7
DOIs	https://doi.org/10.21037/tlcr.2018.04.14
Publication status	Published - 26 Sept 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{89deb543f8ec41fd8aac592f35130df6,

title = "Is more the better?-cetuximab in non-small cell lung cancer patients",

author = "Teresa Moran",

year = "2018",

month = sep,

day = "26",

doi = "10.21037/tlcr.2018.04.14",

language = "English",

volume = "7",

pages = "S195--S197",

journal = "Translational Lung Cancer Research",

issn = "2218-6751",

publisher = "Society for Translational Medicine (STM)",

}

TY - JOUR

T1 - Is more the better?-cetuximab in non-small cell lung cancer patients

AU - Moran, Teresa

PY - 2018/9/26

Y1 - 2018/9/26

UR - http://www.scopus.com/inward/record.url?scp=85054472111&partnerID=8YFLogxK

U2 - 10.21037/tlcr.2018.04.14

DO - 10.21037/tlcr.2018.04.14

M3 - Review article

AN - SCOPUS:85054472111

SN - 2218-6751

VL - 7

SP - S195-S197

JO - Translational Lung Cancer Research

JF - Translational Lung Cancer Research

ER -